BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $CYTK readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06736574-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270901
DTEND;VALUE=DATE:20270902
SUMMARY:~COMET-HF readout (P3) · Cytokinetics $CYTK
DESCRIPTION:Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Hea
 rt Failure With Severely Reduced Ejection Fraction\n\nPrimary completion d
 ate: 2027-09 (estimated) — month only\, shown on the 1st\nPhase 3 · Car
 dio-Met · Heart Failure\, Heart Failure With Reduced Ejection Fraction\nE
 nrollment: 1800 · Sites: 213\n\nPrimary completion = last participant's p
 rimary-endpoint data collected\; topline results usually follow weeks to m
 onths later. Sponsor-reported\, often an estimate. Not investment advice.\
 n\nhttps://datacutoff.com/radar.html?nct=NCT06736574\nhttps://clinicaltria
 ls.gov/study/NCT06736574
URL:https://datacutoff.com/radar.html?nct=NCT06736574
CATEGORIES:Cardio-Met,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
